XML 51 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 15 - Unaudited Quarterly Results (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2017
Notes Tables  
Quarterly Financial Information [Table Text Block]
   
2017 Quarter Ended
  
   
March 31
    
June 30
    
September 30
    
December 31
  
Revenues
   $
2,347
     $
2,765
     $
2,697
     $
3,889
  
Net (loss) income
   $
(16,360
 )   $
(16,636
 )   $
(15,352
 )   $
(2,665
 )
Net loss attributable to noncontrolling interests
   $
-
     $
-
     $
-
     $
-
  
Net (loss) income attributable to Progenics
   $
(16,360
 )   $
(16,636
 )   $
(15,352
 )   $
(2,665
 )
Net (loss) income per share attributable to Progenics - basic
   $
(0.23
 )   $
(0.24
 )   $
(0.22
 )   $
(0.04
 )
Net (loss) income per share attributable to Progenics - diluted
   $
(0.23
 )   $
(0.24
 )   $
(0.22
 )   $
(0.04
 )
   
2016 Quarter Ended
  
   
March 31
    
June 30
    
September 30
    
December 31
  
Revenues
(1)
   $
2,450
     $
8,476
     $
53,850
     $
4,653
  
Net (loss) income
   $
(12,673
 )   $
(5,657
 )   $
36,282
     $
(7,219
 )
Net loss attributable to noncontrolling interests
   $
(18
 )   $
(19
 )   $
(21
 )   $
(15
 )
Net (loss) income attributable to Progenics
   $
(12,655
 )   $
(5,638
 )   $
36,303
     $
(7,204
 )
Net (loss) income per share attributable to Progenics - basic
   $
(0.18
 )   $
(0.08
 )   $
0.52
     $
(0.10
 )
Net (loss) income per share attributable to Progenics - diluted
   $
(0.18
 )   $
(0.08
 )   $
0.52
     $
(0.10
 )